NIP
XENT

Nicholas Investment Partners’s Intersect ENT, Inc XENT Stock Holding History

Nicholas Investment Partners’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-55,686
Closed -$2.19M – 259
2018
Q1 		$2.19M Buy
+55,686
New +$2.03M 0.16% 186
2015
Q3 		– Sell
-94,392
Closed -$2.7M – 335
2015
Q2 		$2.7M Sell
94,392
-30,259
-24% -$793K 0.17% 226
2015
Q1 		$3.22M Buy
+124,651
New +$2.85M 0.2% 208

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Nicholas Investment Partners's XENT Position: Q2 2018 in Review

Nicholas Investment Partners sold out of Intersect ENT, Inc (XENT) in Q2 2018, closing a stake of 55,686 shares — an estimated $2.19M sold.

Nicholas Investment Partners first reported a position in XENT in Q1 2015 and held it in 3 quarters. The position peaked at $3.22M in Q1 2015. 160 funds tracked by Wall St. Rank hold XENT as of Q2 2018.

  • Nicholas Investment Partners reported no remaining Intersect ENT, Inc position as of Q2 2018 after selling out during the quarter.
  • Nicholas Investment Partners sold 55,686 Intersect ENT, Inc shares in Q2 2018, an estimated $2.19M.
  • Nicholas Investment Partners first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 3 quarters.
  • Nicholas Investment Partners's Intersect ENT, Inc position peaked at $3.22M in Q1 2015.
  • 160 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2018.

Based on Nicholas Investment Partners's 13F filing for Q2 2018, filed 14 Aug 2018.